Stay updated on Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.

Latest updates to the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.2 has been added to the page. Revision: v3.2.0 has been removed from the page.SummaryDifference0.1%

- Check12 days agoChange DetectedThe funding lapse banner is removed from the page. Study details, eligibility criteria, and location/contact information remain unchanged.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNo significant updates to core study details were observed; the page content, including title, status, eligibility criteria, interventions, primary outcomes, locations, and enrollment, remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check62 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.